Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Itir Yegenaga"'
Autor:
Meltem Gursu, Itir Yegenaga, Serhan Tuglular, Belda Dursun, Sibel Gokcay Bek, Simge Bardak, Engin Onan, Serap Demir, Ulver Derici, Ayhan Dogukan, Mustafa Sevinc, Ismail Kocyigit, Eda Altun, Ali Burak Haras, Mehmet Riza Altiparmak, Halil Zeki Tonbul
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background This study aimed to evaluate the etiologies, comorbidities, and outcomes of acute kidney injury (AKI) in Turkey and determine any potential differences among different geographical parts of the country. Methods This prospective ob
Externí odkaz:
https://doaj.org/article/9a6f94e0cac34269911cb737b0111e26
Publikováno v:
Maltepe Tıp Dergisi.
A chronic myeloid leukemia (CML) case following acute kidney injury (AKI) was reported here. 80 year old man, admitted to the clinic with oliguria and increasing in serum urea and creatinine levels. He was diagnosed as acute kidney injury (AKI) and t
Publikováno v:
Case Reports in Nephrology, Vol 2014 (2014)
Introduction. Liver involvement due to hyperthyroidism and also ANCA positive vasculitis related renal failure cases were reported separately several times before. However, to our knowledge, these two complications together in the same case had never
Externí odkaz:
https://doaj.org/article/0c871dccdc3e42c7af293f4e65380b56
Autor:
Koray Celebi, Itir Yegenaga, Necmi Eren, Canan Baydemir, Fatih Kamis, Nur Baykara, Elizade Erdem
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 55:190-197
Aims The prevention of acute kidney injury can be lifesaving for the intensive care unit patients. However, conventional methods are not sufficient for the prediction of the risk of future acute kidney injury. In this study, the promising biomarker,
Autor:
Sibel Gokcay Bek, Mert Musul, Betul Kalender, Nur Baykara, Canan Baydemir, Fatih Kamis, Itir Yegenaga
Publikováno v:
Journal of Critical Care. 34:89-94
The recognition of acute kidney injury (AKI) as early as possible is important in the intensive care unit. This study proposes that serum and urine levels of neutrophil gelatinase-associated lipocalin (NGAL) may be used for this purpose.One hundred a
Autor:
Zeki Aydin, Itir Yegenaga
Publikováno v:
BANTAO Journal, Vol 12, Iss 1, Pp 40-44 (2015)
Introduction. Anemia is a complication of chronic renal failure observed in patients on hemodialysis (HD) affecting morbidity and mortality of these patients. It is associated with erythropoietin (EPO) deficiency and can be treated by human recombina
Autor:
Zeynep Mine Solak, Nilay Etiler, Sinan Torlak, Elif Ari, Kamil Toker, Türkay Akbaş, Sertan Acar, Nur Baykara, Itir Yegenaga, Serhan Tuglular
Publikováno v:
Nephron Clinical Practice. 115:c276-c282
Sepsis is a common cause of acute renal failure in intensive care units (ICU) with mortality rates as high as 60%. In this study, the clinical and laboratory predictors of acute kidney injury (AKI) in critically ill Turkish patients with sepsis/syste
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142934 (2015)
PLoS ONE
PLoS ONE
The relationship between the stem cells and the bone turnover in uremic bone disease due to chronic renal failure (CRF) is not described. The aim of this study was to investigate the effect of bone turnover status on stem cell properties. To search f
Autor:
Wim Van Biesen, E. Hoste, Gulcin Kantarci, Dominique Benoit, Raymond Vanholder, Itir Yegenaga, Annemieke Dhondt, Francis Colardyn, Norbert Lameire
Publikováno v:
American Journal of Kidney Diseases. 43:817-824
Acute renal failure (ARF) in patients with sepsis provokes high mortality and financial cost. In this prospective study, we collected characteristics of patients in the intensive care unit (ICU) who developed sepsis/systemic inflammatory response syn
Autor:
Ekrem Erek, Omer Uysal, Betul Kalender, Itir Yegenaga, Melek Öztürk, Fatma Kaya Dağıstanlı, Matem Tunçdemir
Publikováno v:
Acta Histochemica. 104:123-130
Effects of the angiotensin II type 1 (AT1) receptor antagonist valsartan and the angiotensin-converting enzyme (ACE) inhibitor enalapril were studied in streptozotocine (STZ)-induced diabetes in rats on the basis of microalbuminuria (Ma) and renal mo